Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressPharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malariaStatin Use and Risk of Cirrhosis and Related Complications in Patients with Chronic Liver Diseases: a Systematic Review and Meta-analysis.Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseStatin use in patients with cirrhosis: a retrospective cohort study.Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver CirrhosisSalvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II SignalingIdentification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexiaStatins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice.Rationale for the use of statins in liver disease.Effect of prostaglandin E1 on TNF-induced vascular inflammation in human umbilical vein endothelial cells.Antifibrotic effect of AT-1 blocker and statin in rats with hepatic fibrosis.Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats.Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells.Assessment of hepatic function, oxidant/antioxidant status, and histopathological changes in rats treated with atorvastatin: Effect of dose and acute intoxication with acetaminophen.Effect of AGTR1 and BDKRB2 gene polymorphisms on atorvastatin metabolism in a Mexican population.Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide.Targeting the renin-angiotensin system in liver fibrosis.Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats.Protective effects of enalapril, an angiotensin-converting enzyme inhibitor, on multiple organ damage following scald injury in rats.The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats
P2860
Q24306614-FD42F801-6585-4154-B80A-34D295D2B269Q27023122-2B338F0D-9B19-4671-9599-4330AAD49F58Q28486022-B9FA274D-71F4-452B-A024-AA9D019569FFQ30234533-77A1C79F-FC44-4743-95DC-4B4086DF717EQ33607697-A2D8B925-E515-4BAC-9D50-276489F435EEQ34661975-6AA52B44-0545-4899-AB60-5980B3764358Q35787734-6E963318-61C2-4982-A20D-C0291E5A8324Q36456025-5C7C79E2-F90C-48E6-BE8C-827A978E075AQ36707757-A92EFD82-292F-46B7-8818-C6C963885319Q37348597-E3CE3DC1-7A99-427A-82D2-AF3E5090133AQ39171942-1B292353-2DA9-47E8-882F-FAEBB3EF6F0DQ39691798-61BF1D62-33A1-4190-B06D-F8CB97003F3FQ40736144-A0DBA9D0-6A41-4994-86A2-C50C1D47B7B4Q41029212-939A61EC-5812-4D49-8B0D-FF7643AE4CE9Q41848559-6030886A-7FDD-47F6-B58F-59712AA0D9C2Q44743116-F759C5ED-1805-4D80-A10E-015D0C3354CCQ45832826-DDFABDFF-2248-4DCC-9F9F-FE2CDE972310Q46577508-A098BA42-984D-4072-A009-DC8BBD53EC9BQ47110674-575D21BA-7457-44A4-8FBC-51F937169119Q47272307-AE337273-9A0E-4543-8283-FA9E9396A569Q50223405-C54B46BC-7BD2-499C-93C0-3DF02E9B7E7EQ50238685-1709B866-8860-44B2-9703-EA555616A320Q50937968-35364767-0B70-48E5-B048-E866C6908321Q51250930-8762E6D1-ED55-4A3D-9635-262FD5B29BCBQ57147093-01B3A9AA-23CE-4542-91A5-8621182D08C8
P2860
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
@en
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
@nl
type
label
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
@en
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
@nl
prefLabel
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
@en
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
@nl
P2093
P2860
P50
P356
P1476
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
@en
P2093
Jesús Egido
Marlene Dominguez
Marta Ruiz-Ortega
Montserrat Moreno
Ramón Bataller
P2860
P304
P356
10.1152/AJPGI.00462.2007
P50
P577
2008-12-04T00:00:00Z